CHARACTERIZATION OF THE GENETIC ARCHITECTURE OF THE HUMAN ANTIVIRAL RESPONSE AT THE EPITOPE LEVEL

Abstract

Integrating host genetics with the antibody response to viral infections may aid our understanding of inter-individual differences in immune response and disease outcomes. The antibody response to viral peptides was characterized using VirScan which allows for high- throughput antibody profiling of viral epitopes. We study the genetics of the antibody response to 52 Epstein-Barr Virus (EBV) and 52 Human Adenovirus (HAdv) prevalent peptides in a cohort of 625 unrelated participants of European and African ancestry and an independent cohort of 494 twins from UK. We identified 4 epitopes of EBV that were heritably targeted, and at least two EBNA-2 binding specificities that were associated with variants in the MHC class-II locus. Similarly, we identified genetic associations in the HLA Class-II genes with the long-term antibody response to protein peptides in the core proteins V, VII and minor capsid protein VIII of HAdv. Furthermore, we performed an in-silico finemapping of these HLA-associated regions and identified the specific classical alleles and amino acids in the DQB1 and DRB1 genes implicated in the long-term antibody response to the EBNA-2 and the minor capsid protein VIII of HAdv. This demonstrates that specific amino acid variation in the HLA-class II influence the long-term viral antibody response in an epitope specific manner

    Similar works